MEGAN KAIN: Open Payments
NPI 1780153239 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,719 in 101 payments from 16 companies in 2025. Trend: 2023 $2,324 · 2024 $2,352 · 2025 $3,719
Food & beverage: $2,515Consulting: $1,125Education: $79
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $1,462 |
| ABBVIE INC. | 29 | $513 |
| GENZYME CORPORATION | 7 | $367 |
| Galderma Laboratories, L.P. | 8 | $268 |
| LEO Pharma Inc. | 7 | $182 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $169 |
| UCB, Inc. | 7 | $146 |
| Novartis Pharmaceuticals Corporation | 6 | $139 |
| Incyte Corporation | 4 | $117 |
| Amgen Inc. | 3 | $80 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, RINVOQ, NEMLUVIO, ADBRY, Winlevi, Bimzelx.
Industry payments across NC — which companies pay providers there.
